Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2011 Jan;80(1):33-41.

Optimal management of peripheral arterial disease for the non-specialist

Affiliations
Review

Optimal management of peripheral arterial disease for the non-specialist

M E O'Donnell et al. Ulster Med J. 2011 Jan.

Abstract

Peripheral arterial disease (PAD) now affects approximately 20% of adults older than 55 years to an estimated total of 27 million people in the Western World. The aim of this paper is to describe the medical management of PAD for the non-vascular specialist, particularly general practitioners, where PAD has now been included in the Northern Ireland Department of Health's Primary Care Service Framework (Directed Enhanced Service).

Keywords: Epidemiology; Investigation; Peripheral Arterial Disease; Treatment.

PubMed Disclaimer

Figures

Fig 1
Fig 1
Ankle-brachial index – Doppler assessment of dorsalis pedis which is measured using cuff occlusion by a sphygmomanometer and Doppler ultrasound (Super Dopplex® II Huntleigh Healthcare, UK).
Fig 2
Fig 2
Magnetic Resonance Angiogram (MRA) of the peripheral arterial system extending from the abdominal aorta to the pedal vessels which demonstrated bilateral popliteal artery occlusion with surrounding collateralization (Inset figure is patients pre-operative transfemoral angiogram demonstrating bilateral popliteal artery occlusion).
Fig 3
Fig 3
Computerised tomography angiogram of the peripheral arterial system demonstrating proximal disease of both lower limbs extending from the external iliac to the superficial femoral arteries.
Fig 4
Fig 4
Belfast Health and Social Care Trust Referral Pathway for screened or asymptomatic patients.
Fig 5
Fig 5
Belfast Health and Social Care Trust Referral Pathway for patients with intermittent claudication.
Fig 6
Fig 6
Belfast Health and Social Care Trust Referral Pathway for patients with critical ischaemia.
Figure 7
Figure 7
Belfast Health and Social Care Trust Referral Pathway for patients with diabetes and renal failure.

Similar articles

Cited by

References

    1. Sigvant B, Wiberg-Hedman K, Bergqvist D, Rolandsson O, Andersson B, Persson E, et al. A population-based study of peripheral arterial disease prevalence with special focus on critical limb ischemia and sex differences. J Vasc Surg. 2007;45(6):1185–91. - PubMed
    1. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG, et al. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II) Eur J Vasc Endovasc Surg. 2007;33(Suppl 1):S1–75. - PubMed
    1. Schmieder FA, Comerota AJ. Intermittent claudication: magnitude of the problem, patient evaluation, and therapeutic strategies. Amer J Cardiol. 2001;87(12A):3D–13D. - PubMed
    1. McDermott MM. The magnitude of the problem of peripheral arterial disease: epidemiology and clinical significance. Cleve Clin J Med. 2006;73(Suppl 4):S2–7. - PubMed
    1. Second European Consensus Document on chronic critical leg ischaemia, editor. Eur J Vasc Surg. 1992;6(Supp A):1–32. - PubMed

LinkOut - more resources